Pathways for outpatient management of venous thromboembolism in a UK centre

被引:13
作者
Condliffe R. [1 ]
机构
[1] Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield
关键词
Deep vein thrombosis; Oral anticoagulant; Patient pathway; Pulmonary embolism; Venous thromboembolism;
D O I
10.1186/s12959-016-0120-2
中图分类号
学科分类号
摘要
It has become widely recognised that outpatient treatment may be suitable for many patients with venous thromboembolism. In addition, non-vitamin K antagonist oral anticoagulants that have been approved over the last few years have the potential to be an integral component of the outpatient care pathway, owing to their oral route of administration, lack of requirement for routine anticoagulation monitoring and simple dosing regimens. A robust pathway for outpatient care is also vital; one such pathway has been developed at Sheffield Teaching Hospitals in the UK. This paper describes the pathway and the arguments in its favour as an example of best practice and value offered to patients with venous thromboembolism. The pathway has two branches (one for deep vein thrombosis and one for pulmonary embolism), each with the same five-step process for outpatient treatment. Both begin from the point that the patient presents (in the Emergency Department, Thrombosis Clinic or general practitioner's office), followed by diagnosis, risk stratification, treatment choice and, finally, follow-up. The advantages of these pathways are that they offer clear, evidence-based guidance for the identification, diagnosis and treatment of patients who can safely be treated in the outpatient setting, and provide a detailed, stepwise process that can be easily adapted to suit the needs of other institutions. The approach is likely to result in both healthcare and economic benefits, including increased patient satisfaction and shorter hospital stays. © 2016 The Author(s).
引用
收藏
相关论文
共 36 条
  • [1] Konstantinides S.V., Torbicki A., Agnelli G., Danchin N., Fitzmaurice D., Galie N., Et al., 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism, Eur Heart J, 35, pp. 3033-3069, (2014)
  • [2] Aujesky D., Roy P.M., Verschuren F., Righini M., Osterwalder J., Egloff M., Et al., Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial, Lancet, 378, pp. 41-48, (2011)
  • [3] Zondag W., Mos I.C., Creemers-Schild D., Hoogerbrugge A.D., Dekkers O.M., Dolsma J., Et al., Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study, J Thromb Haemost, 9, pp. 1500-1507, (2011)
  • [4] Condliffe R., Elliot C.A., Hughes R.J., Hurdman J., Maclean R.M., Sabroe I., Et al., Management dilemmas in acute pulmonary embolism, Thorax, 69, pp. 174-180, (2014)
  • [5] Yoo H.H., Queluz T.H., Dib R., Outpatient versus inpatient treatment for acute pulmonary embolism, Cochrane Database Syst Rev, 11, (2014)
  • [6] Robertson L., Kesteven P., McCaslin J.E., Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis, Cochrane Database Syst Rev, 6, (2015)
  • [7] Khanbhai M., Hansrani V., Burke J., Ghosh J., McCollum C., The early management of DVT in the North West of England: a nation-wide problem?, Thromb Res, 136, pp. 76-86, (2015)
  • [8] The Prevention of Venous Thromboembolism in Hospitalised Patients
  • [9] Second Report of Session 2004-05, (2016)
  • [10] Venous thromboembolism: reducing the risk for patients in hospital, Recommendations, 1, (2016)